Clinical trial
Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy
NCT05761912 is registered in ClinicalTrials.gov with Shanghai Minhang Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy
- Lead sponsor
- Shanghai Minhang Central Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 23, 2025
- Completion date
- October 25, 2026
- Enrollment
- 160 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer, radiomics, ultrasound